(20S)-ginsenoside Rh1 is a tetracyclic triterpenoid that is (20S)-protopanaxadiol which is substituted by beta-D-glucoside at the 6alpha position.
定義
(20S)-ginsenoside Rh1 is a tetracyclic triterpenoid that is (20S)-protopanaxadiol which is substituted by beta-D-glucoside at the 6alpha position. It has a role as a plant metabolite. It is a 3beta-hydroxy-4,4-dimethylsteroid, a beta-D-glucoside, a tetracyclic triterpenoid, a 3beta-hydroxy steroid, a 12beta-hydroxy steroid and a ginsenoside. It derives from a hydride of a dammarane.
出典: PubChem
Ginsenoside Rh1 is the saponin isolated from Panax ginseng that conforms to the formula:
米国FDA 物質登録 · UNII XBR6F7G8FU · 登録名 GINSENOSIDE RH1, (20S)- · 単一の化学物質
化粧品での役割
肌に水分を引き寄せるSKIN CONDITIONING - HUMECTANT髪をやわらかくするHAIR CONDITIONING
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
GINSENOSIDE RH1INCI진세노사이드알에이치1韓国の表示名（食薬処標準名）
- CAS No.化学物質登録番号
- 63223-86-9
- DTXSID米国EPA化学物質番号
- DTXSID80979245
- DTXCID米国EPA化合物番号
- DTXCID601776153
- IUPAC
- 3beta,12beta,20-Trihydroxydammar-24-en-6alpha-yl beta-D-glucopyranoside
- 分子式
- C36H62O9
- 分子量
- 638.883 g/mol
関連文献
- Cream formulation improved skin-lightening effect of ginsenoside Rh1, Rg2, and Hydrangea macrophylla flower extract · 2023
- Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway · 2022
- Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice. · 2011
- Ginsenoside Rh1 Possesses Antiallergic and Anti-Inflammatory Activities · 2004